FDA commissioner
This article was originally published in The Rose Sheet
Executive Summary
Acting chief Andrew von Eschenbach, MD, is nominated by President Bush to head the agency permanently March 15. Von Eschenbach assumed the acting role last fall following the resignation of FDA Commissioner Lester Crawford (1"The Rose Sheet" Oct. 3, 2005, p. 6). Road to confirmation may be a rocky one, however: Sens. Hillary Clinton (D-N.Y.) and Patty Murray (D-Wash.) threatened to place a hold on nomination until FDA issues a decision on over-the-counter switch application for Barr's Plan B emergency contraceptive...